Publication date: May 14, 2019
In order to avoid the undesirable side effects of the cancer medication, the investigation of synthetic peptides, which could be used as active ingredients in the medication, is very important.
The team behind the project in KTU, Lithuania is led by Professor Algirdas Šačkus and made up of Dr Greta Ragaitė, Dr Neringa Kleizienė, and master’s students Aistė Kveselytė and Urtė Šachlevičiūtė.
“The almost year-long project bore fruit,” said Dr Neringa Kleizienė, “we have created building blocks, which will be the ingredients in synthetic peptides that will allow us to create anti-cancer medicine prototypes. “